Ken Griffin’s ProShares UltraShort Health Care RXD Stock Holding History

Ken Griffin’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,802	Closed	-$326K	–	15377
2022 Q3	$326K	Buy	+10,802	New	+$291K	﹤0.01%	9386
2020 Q2	–	Sell	-7,177	Closed	-$540K	–	10407
2020 Q1	$540K	Buy	7,177 +2,206	+44%	+$163K	﹤0.01%	6345
2019 Q4	$341K	Sell	4,971 -688	-12%	-$54.5K	﹤0.01%	7399
2019 Q3	$510K	Sell	5,659 -339	-6%	-$29.9K	﹤0.01%	6711
2019 Q2	$514K	Buy	5,998 +685	+13%	+$63.1K	﹤0.01%	6786
2019 Q1	$468K	Buy	+5,313	New	+$491K	﹤0.01%	6903

Other funds holding RXD

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ken Griffin's RXD Position: Q4 2022 in Review

Ken Griffin sold out of ProShares UltraShort Health Care (RXD) in Q4 2022, closing a stake of 10,802 shares — an estimated $326K sold.

Ken Griffin first reported a position in RXD in Q1 2019 and held it in 6 quarters. The position peaked at $540K in Q1 2020. 3 funds tracked by Wall St. Rank hold RXD as of Q4 2022.

Ken Griffin reported no remaining ProShares UltraShort Health Care position as of Q4 2022 after selling out during the quarter.
Ken Griffin sold 10,802 ProShares UltraShort Health Care shares in Q4 2022, an estimated $326K.
Ken Griffin first reported a position in ProShares UltraShort Health Care in Q1 2019 and held it in 6 quarters.
Ken Griffin's ProShares UltraShort Health Care position peaked at $540K in Q1 2020.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.